Immatics director reports stock option holdings

Immatics N.V. director Alise Reicin reported existing holdings of stock options in the company.

Rhea-AI Filing Summary

Immatics N.V. director Alise Reicin reported existing holdings of stock options in the company. The filing shows options to buy 60,000 ordinary shares at an exercise price of $12.08 per share, expiring on July 28, 2034, vesting in 12 equal quarterly installments over 36 months from the grant date of July 29, 2024. It also lists options to buy 41,500 ordinary shares at an exercise price of $5.44 per share, expiring on June 23, 2035, which vest 100% on the first anniversary of the grant date, June 24, 2025. These entries describe current derivative holdings rather than new open‑market purchases or sales.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider REICIN ALISE

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 101,500 contracts (Direct)

Footnotes (2)

1. F1. These options to purchase ordinary shares of the Issuer (each such option, an "Option") vest in 12 equal quarterly installments over 36 months from the grant date, July 29, 2024.
2. F2. These Options vest 100% on the first anniversary of the grant date, June 24, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position does Alise Reicin hold at Immatics (IMTX)?

Alise Reicin is reported as a director of Immatics N.V. The Form 3 identifies her as a board member, not an officer or 10% owner, and details her existing stock option holdings in the company’s ordinary shares.

What stock options does Alise Reicin hold in Immatics (IMTX)?

She holds two stock option positions in Immatics N.V. One covers 60,000 ordinary shares at $12.08 per share, and another covers 41,500 ordinary shares at $5.44 per share, both structured as rights to buy ordinary shares.

How do Alise Reicin’s Immatics (IMTX) options vest?

Her options vest on different schedules. The 60,000-share grant vests in 12 equal quarterly installments over 36 months from July 29, 2024, while the 41,500-share grant vests 100% on June 24, 2025, the first anniversary of its grant date.

When do Alise Reicin’s Immatics (IMTX) stock options expire?

The reported options have long-dated expiration terms. The 60,000-share option position expires on July 28, 2034, and the 41,500-share option position expires on June 23, 2035, if not exercised earlier according to their terms.

Does the Immatics (IMTX) Form 3 show any insider buying or selling?

The Form 3 reflects holdings, not open-market trades. It lists existing stock options with vesting schedules and expiration dates, and the transaction summary shows no recorded buys, sells, exercises, gifts, or tax-withholding transactions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:28 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

REICIN ALISE

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	07/28/2034	Ordinary Shares	60,000	$12.08	D
Stock Option (Right to Buy)	(2)	06/23/2035	Ordinary Shares	41,500	$5.44	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer (each such option, an "Option") vest in 12 equal quarterly installments over 36 months from the grant date, July 29, 2024.

2. These Options vest 100% on the first anniversary of the grant date, June 24, 2025.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Alise Reicin	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)